knowledge -WSS

knowledge

author：fashion 2025-09-28 21:04:46 - browse：525

A doctor climbs up a red ladder to a vine shaped like a DNA — biotech coverage from STAT — Adobe

Every morning, Victoria Rasberry gets up before 6 a.m., walks to the bedroom down the hall, and helps her 8-year-old daughter Addi slide into a set of contraptions that squeeze and suck out the thick mucus constantly threatening to choke her airways closed. She feeds Addi breakfast through a stomach tube and makes sure she has the right mix of the 28 different medications required to keep her free of pain, infections, and seizures. At some point, Rasberry’s five other children will wake up and start to get ready for school, including her youngest, Oliver. At 3-and-a-half years old, he’s a typical toddler — always running and giggling and getting into things. You would never know that he and Addi were born with the same mutation lurking in their DNA, a genetic glitch that causes a fatal neurodegenerative disease called metachromatic leukodystrophy, or MLD.

“When Addi was this age she had lost the ability to speak and was already using a ventilator to sleep at night,” Rasberry said. “It’s amazing to see how well Ollie is doing in comparison. And it’s all because of the gene therapy.”

Three years ago, when Ollie was just 6 months old, he and Victoria traveled from their home in Texas to Milan, to receive a gene therapy treatment that adds a healthy version of the defective gene into patients’ own stem cells. At the time, traveling abroad for the therapy, which is manufactured by Orchard Therapeutics and was approved in Europe in 2021, was the only option for families stricken by MLD. But soon it will be available in the U.S., too.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Why health workers in Gaza are injured or die at high rates

explore

WSS

CEOs share strategies for surviving biotech slump

Donald Trump's relentless attacks on special counsel Jack Smith

Impact of Dobbs ruling felt at reproductive medicine meeting

STAT Summit: GSK CEO on pharma giant's new direction

What is the Wagner Group? The 'brutal' Russian military unit in Ukraine

STAT Summit: How a Chicago ER doctor tackles gun violence

leisure time

knowledge

knowledge

Duchenne breakthrough therapy leaves behind pioneering families

Do masks work? RCTs can't tell us

FDA approval of Sarepta Duchenne genetic therapy gives me hope

In areas with more Black doctors, Black people live longer

United colonoscopy coverage change 'may cost lives,' doctors say

#NeedHerScience: shining a light on gender disparities in medicine

Guidelines to prevent youth baseball injuries need more muscle

Pharmacists can make shortage drugs, but at what cost?

United colonoscopy coverage change 'may cost lives,' doctors say

Lawmakers consider Medicare pay reforms for doctors

explore

FDA grants conditional OK to Sarepta’s gene therapy for Duchenne

Senate committee scrutinizes Medicare Advantage brokers

The story of mRNA: From a loose idea to a tool that may help curb Covid

The strategy behind pharma's lawsuits over drug pricing reform

CEOs share strategies for surviving biotech slump

Colonoscopy at 40? Study finds a possible benefit

explore

hotspot

hotspot

leisure time